NVCR vs SONY
Novocure Ltd (NVCR) versus SONY (SONY) — a side-by-side from cached financials, not a winner call.
Novocure Ltd (NVCR) is a medical devices company listed on US.
SONY (SONY) common stock.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
SONY does not have a complete income-statement cache yet.
NVCR currently screens at market cap $1.99B. SONY currently screens at market cap $0.
Not investment advice. Open the NVCR and SONY stock pages for the full models.
Not investment advice.